The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Paion Ag's share price is $0.0251.
Paion Ag's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.22. Hence, Paion Ag's PS Ratio for today is 0.01.
Good Sign:
Paion Ag stock PS Ratio (=0.01) is close to 10-year low of 0.01
The historical rank and industry rank for Paion Ag's PS Ratio or its related term are showing as below:
PAIOF'
s PS Ratio Range Over the Past 10 Years
Min: 0.01 Med: 20.69 Max: 1955.5
Current: 0.02
During the past 13 years, Paion Ag's highest PS Ratio was 1955.50. The lowest was 0.01. And the median was 20.69.
PAIOF's PS Ratio is ranked better than 99.6% of 1002
companies
in the Drug Manufacturers industry
Industry Median: 2.21
vs PAIOF: 0.02
Paion Ag revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Paion Ag was -48.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 56.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 38.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 7.50% per year.
During the past 13 years, Paion Ag's highest 3-Year average Revenue per Share Growth Rate was 213.90% per year. The lowest was -88.20% per year. And the median was -2.60% per year.
Back to Basics: PS Ratio
Paion Ag PS Ratio Historical Data
The historical data trend for Paion Ag's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Paion Ag's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paion Ag's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Paion Ag's PS Ratio distribution charts can be found below:
* The bar in red indicates where Paion Ag's PS Ratio falls into.
Paion Ag PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Paion Ag's Share Price of today is $0.0251.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Paion Ag's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.22.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Paion Ag PS Ratio Related Terms
Thank you for viewing the detailed overview of Paion Ag's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Paion Ag is a holding company engaged in providing various services to the subsidiaries. The group is focused on developing and commercializing medical innovations for procedural sedation, anesthesia, and critical care services. The key product of the company is remimazolam, which is an ultra-short-acting intravenous benzodiazepine sedative. In the human body, remimazolam is rapidly metabolized to an inactive metabolite by tissue esterases and not metabolized by cytochrome-dependent hepatic pathways. The organization is based in Germany.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PAIOF has been successfully added to your 